Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by porksnifferon Sep 28, 2020 1:12pm
58 Views
Post# 31629417

RE:RE:RE:COVID vaccine related activities in LATAM / JNJ

RE:RE:RE:COVID vaccine related activities in LATAM / JNJ
MrMugsy wrote: No Chianchin, it is not absurd.  We have been saying for a very long time that this one will move sideways until it doesn’t anymore.  Please look way back in our discussions and you will find the constant warnings.

When do shareholders get excited ?  Likely when new investors start climbing on?  Watch for analysts to turn bullish.  Until they start promoting in a big way, this will likely float.

If nothing else, it buys more time for accumulators.

Hope that helps Chianchin.

JMO


LOL SIdeways...LOOOLLL

Are you staring the chart upside down or are you looking at the right chart? Price is not sideways lmao, it has essentially collapsed. And this is with a 'brilliant' CEO. Everything that Meir said would happen has happened.

I continue to laugh at you, you are down on every share. LMAO. I remember you at $9,$8,$7 $6 pounding the table allegedly 'accumulating' claiming this will soar. Let me guess, you are still buying LOL. Covid crash aside this is now the LOWEST price it's been in...6 years. It means every shareholder who bought is a loser. SIX YEARS. Let that sink in.




Bullboard Posts